Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 2536 AL 2550

Nonpeptide neurotrophic agents useful in the treatment of neurodegenerative diseases such as Alzheimer's disease

Akagi M, Matsui N, Akae H, Hirashima N, Fukuishi N, Fukuyama Y, Akagi R.

J Pharmacol Sci. 2015 Feb;127(2):155-63. doi: 10.1016/j.jphs.2014.12.015. Epub 2015 Jan 13.

Globus pallidus interna deep brain stimulation for chorea-acanthocytosis

Lee JH, Cho WH, Cha SH, Kang DW.

J Korean Neurosurg Soc. 2015 Feb;57(2):143-6. doi: 10.3340/jkns.2015.57.2.143. Epub 2015 Feb 26.

Cholinesterase inhibitors for rarer dementias associated with neurological conditions

Li Y, Hai S, Zhou Y, Dong BR.

Cochrane Database Syst Rev. 2015 Mar 3;2015(3):CD009444. doi: 10.1002/14651858.CD009444.pub3.

Biallelic mutations in huntington disease: A new case with just one affected parent, review of the literature and terminology

Uhlmann WR, Peñaherrera MS, Robinson WP, Milunsky JM, Nicholson JM, Albin RL.

Am J Med Genet A. 2015 May;167A(5):1152-60. doi: 10.1002/ajmg.a.37009. Epub 2015 Mar 3.

Mixed movements disorders as an initial feature of pediatric lupus

Mrabet S, Benrhouma H, Kraoua I, Naas A, Achour NB, Klaa H, Turki I.

Brain Dev. 2015 Oct;37(9):904-6. doi: 10.1016/j.braindev.2015.01.008. Epub 2015 Feb 28.

Engineering enhanced protein disaggregases for neurodegenerative disease

Jackrel ME, Shorter J.

Prion. 2015;9(2):90-109. doi: 10.1080/19336896.2015.1020277.

Developments in intracerebral stem cell grafts

Reyes S, Tajiri N, Borlongan CV.

Expert Rev Neurother. 2015 Apr;15(4):381-93. doi: 10.1586/14737175.2015.1021787. Epub 2015 Mar 5.

The emerging role of the first 17 amino acids of huntingtin in Huntington's disease

Arndt JR, Chaibva M, Legleiter J.

Biomol Concepts. 2015 Mar;6(1):33-46. doi: 10.1515/bmc-2015-0001.

[Gene silencing approaches for the treatment of Huntington's disease]

Merienne N, Déglon N.

Med Sci (Paris). 2015 Feb;31(2):159-67. doi: 10.1051/medsci/20153102012. Epub 2015 Mar 4.

Generalized chorea due to delayed encephalopathy after acute carbon monoxide intoxication

Sung YF, Chen MH, Peng GS, Lee JT.

Ann Indian Acad Neurol. 2015 Jan-Mar;18(1):108-10. doi: 10.4103/0972-2327.144288.

Hemichorea in a diabetes mellitus patient following acute ischemic stroke with changes in regional cerebral blood flow

Suzuki Y, Oishi M, Kanno A, Ogawa K, Fujisawa M, Kamei S.

J Chin Med Assoc. 2015 Mar;78(3):188-91. doi: 10.1016/j.jcma.2013.12.004. Epub 2015 Mar 4.

Selective loss of oxytocin and vasopressin in the hypothalamus in early Huntington disease: a case study

Gabery S, Halliday G, Kirik D, Englund E, Petersén Å.

Neuropathol Appl Neurobiol. 2015 Oct;41(6):843-8. doi: 10.1111/nan.12236. Epub 2015 Jun 2.

Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies

Ciechanover A, Kwon YT.

Exp Mol Med. 2015 Mar 13;47(3):e147. doi: 10.1038/emm.2014.117.

Noninvasive prenatal diagnosis of Huntington disease: detection of the paternally inherited expanded CAG repeat in maternal plasma

van den Oever JM, Bijlsma EK, Feenstra I, Muntjewerff N, Mathijssen IB, Bakker E, van Belzen MJ, Boon EM.

Prenat Diagn. 2015 Oct;35(10):945-9. doi: 10.1002/pd.4593. Epub 2015 Apr 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias